There is nothing in small-caps to suggest that they are as frothy as the big-caps.
The clinical stage company sees its shares climb after announcing some significant news during this week's J.P. Morgan Healthcare Conference.
The banks, smalls caps and transportation stocks finally catch up.
My approach to this sort of action is to forget the indices and focus on managing your individual positions.
As the small- and mid-caps lag vs. large ones, we see that the Top 5 stocks in the S&P 500 account for 17% of the index -- here are the three ways this could shake out.
Aquestive Therapeutics, Chiasma Inc. and Eton Pharmaceuticals each appear to have good prospects in 2020.
A solid fourth-quarter report could bring momentum players back to this Israeli company with great growth potential.
The Medical Technology Stock Letter's top pick rose 357% in 2019.
This feels like a combination of poor positioning and a short squeeze.
The antibiotics maker recently received a significant federal contract that could help give its shares the juice they need to climb next year.